Oragenics, Inc.   Report issue

For profit Phase 2
Founded: Tampa FL United States (1996)

Organization Overview

First Clinical Trial
2017
NCT03234465
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Oragenics, Inc.